Floatz logo

CYCLOHEXANEACETIC ACID, 1-(AMINOMETHYL)-

Failed Back Surgery Syndrome

Al-Kindy College of MedicineSmall moleculePhase 4 / ApprovedActive
BB
66/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
51/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Failed Back Surgery Syndrome cohort.

Asset / SponsorPhaseRating
FENTANYL
University Hospitals Cleveland Medical Center
Phase 4BB
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE
University Hospitals Cleveland Medical Center
Phase 4BB
Pregabalin
Al-Kindy College of Medicine
Phase 4BB
BETAMETHASONE
Puerta de Hierro University Hospital
N/AD
Hyaluronidase
EPC Education s.r.o.
N/AD
Nanocis
Poitiers University Hospital
N/AD
Nanocoll
Poitiers University Hospital
N/AD

Same molecule, other indications

CYCLOHEXANEACETIC ACID, 1-(AMINOMETHYL)- is also rated in:

diabetic neuropathyDormant
BBB
Indicative ·
79 / 100
View asset →
Neuralgia, PostherpeticDormant
BBB
Indicative ·
77 / 100
View asset →
focal epilepsyDormant
BBB
Indicative ·
77 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →